Prognostic value of dobutamine stress echocardiography in diabetic patients

International Journal of Cardiovascular Imaging

Volumn 26, Issue 5, 2010, Pages 499-507

  Innocenti, Francesca ^a   Agresti, Chiara ^a   Baroncini, Caterina ^a   Caldi, Francesca ^a   Mannucci, Edoardo ^a   Monami, Matteo ^a   Pini, Riccardo ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Diabetes mellitus; Dobutamine stress echocardiography; Ischemic heart disease; Viability

Indexed keywords

ATROPINE; DOBUTAMINE; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

AGED; AGING; ARTICLE; CAUSE OF DEATH; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE DURATION; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; PHARMACOLOGIC STRESS TESTING; PREDICTION; PROGNOSIS; CHI SQUARE DISTRIBUTION; COMORBIDITY; DIABETIC ANGIOPATHY; ECHOGRAPHY; EXERCISE TEST; HEART FAILURE; METHODOLOGY; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; REST; RISK FACTOR; SURVIVAL;

AGED; CARDIOTONIC AGENTS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CORONARY DISEASE; DIABETIC ANGIOPATHIES; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REST; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 77955494746     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-010-9598-z     Document Type: Article

References (24)

1. Mukamal KJ, Nesto RW, Cohen MC et al (2001) Impact of diabetes on long-term survival after acute myocardial infarction-comparability of risk with prior myocardial infarction. Diabetes Care 24:1422-1427 (Pubitemid 33716431)
2. Barsness GW, Peterson ED, Ohman EM et al (1997) Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 96:2551-2556 (Pubitemid 27451345)
3. Bacci S, Villella M, Villella A et al (2002) Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol 147:649-654 (Pubitemid 35414563)
4. Kim C, Kwok YS, Heagerty P, Redberg R (2001) Pharmacologic stress testing for coronary disease diagnosis: a meta-analysis. Am Heart J 142:934-944 (Pubitemid 33131799)
5. Chuah SC, Pellikka PA, Roger VL, McCully RB, Seward JB (1998) Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 97:1474-1480 (Pubitemid 28191303)
6. Sicari R, Picano E, Cortigiani L et al (2003) Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol 92:1263-1266 (Pubitemid 37431131)
7. Coisne D, Donal E, Torremocha F, Christiaens L, Allal J (2001) Dobutamine stress echocardiography response of asymptomatic patients with diabetes. Echocardiography 18:373-379 (Pubitemid 32692308)
8. Marwick TH, Case C, Sawada S, Vasey C, Short L, Lauer M (2002) Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 25:1042-1048 (Pubitemid 41110491)
9. Bigi R, Desideri A, Cortigiani L, Bax JJ, Celegon L, Fiorentini C (2001) Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care 24:1596-1601 (Pubitemid 33716455)
10. Geleijnse ML, Fioretti PM, Roelandt JR (1997) Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 30:595-606 (Pubitemid 27397635)
11. Armstrong WF, Pellikka PA, Ryan T, Crouse L, Zoghbi WA (1998) Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress echocardiography task force of the nomenclature and standards committee of the American society of echocardiography. J Am Soc Echocardiogr 11:97-104
12. Weiss JS, Sumpio BE (2006) Review of prevalence and outcome of vascular disease in patients with diabetes mellitus. Eur J Vasc Endovasc Surg 31:143-150 (Pubitemid 43078941)
13. Muggeo M, Verlato G, Bonora E et al (1995) The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 38:318-325
14. Wei M, Gaskill SP, Haffner SM, Stern MP (1998) Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio heart study. Diabetes Care 21:1167-1172 (Pubitemid 28368527)
15. Bruno G, Merletti F, Boffetta P et al (1999) Impact of glycemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population based cohort of type II (non-insulin-dependent) diabetes mellitus. Diabetologia 42:297-301 (Pubitemid 29111435)
16. Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with microvascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412 (Pubitemid 30609442)
17. Fateh-Moghadam S, Reuter T, Htun P, Plockinger U, Dietz R, Bocksch W (2009) Stress echocardiography for risk stratification of asymptomatic patients with type 2 diabetes mellitus. Int J Cardiol 131:288-290
18. Chaowalit N, Arruda AL, McCully RB, Bailey KR, Pellikka PA (2006) Dobutamine stress echocardiography in patients with diabetes mellitus: enhanced prognostic prediction using a simple risk score. J Am Coll Cardiol 47:1029-1036
19. Schinkel AF, Poldermans D, Elhendy A, Bax JJ (2006) Prognostic role of dobutamine stress echocardiography in myocardial viability. Curr Opin Cardiol 21:443-449 (Pubitemid 44215009)
20. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39:1151-1158 (Pubitemid 34267418)
21. Chareonthaitawee P, Gersh BJ, Araoz PA, Gibbons RJ (2005) Revascularization in severe left ventricular dysfunction: the role of viability testing. J Am Coll Cardiol 46:567-574 (Pubitemid 41132679)
22. Rizzello V, Poldermans D, Schinkel AF et al (2006) Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart 92:239-244 (Pubitemid 43131969)
23. Sicari R, Picano E, Landi P et al (1997) Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) study. J Am Coll Cardiol 29:254-260 (Pubitemid 27059952)
24. Sozzi FB, Elhendy A, Roelandt JR et al (2003) Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care 26:1074-1078 (Pubitemid 36929251)